Overview

Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
0
Participant gender:
All
Summary
Local anaesthesia is considered one of the most alarming and non-comfortable dental procedures for children. This goes back to the persisting effect of the local anaesthesia after finishing dental procedures. The effect of Local anaesthesia can last from 3 to 5 hours due to the presence of vasoconstrictor. The U.S Food and Drug Administration (FDA approved the use of phentolamine mesylate (Oraverse) in May 2008 to be used as a drug in reversing the numbing effect of Local anaesthesia by decreasing the time needed to restore the normal functions of the mouth
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Cairo University
Treatments:
Phentolamine
Criteria
Inclusion Criteria:

Children aged 6-8 years.

- Patients in need of dental procedures requiring local anaesthesia.

- Healthy Children without any systemic or mental disorders.

- Normal lip sensation before administration of LA.

- Normal paediatric functional assessment battery (pFAB) for smiling, speaking and
drinking and absence of drooling.

Exclusion Criteria:

- Children seeking dental treatment that does not necessitate local anaesthesia.

- Children who didn't achieve profound numbness requiring additional anaesthesia.

- Children who lack the ability to distinct the anaesthetised numb side from the
non-anaesthetised one.

- Children who are not willing to participate in the study.